[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=13f71f214bece77ced5b8014cba9e6de5888d37f4847a7c3d2bfcefe7673dc6a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732207320,
      "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 131601742,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=13f71f214bece77ced5b8014cba9e6de5888d37f4847a7c3d2bfcefe7673dc6a"
    }
  },
  {
    "ts": null,
    "headline": "HQH: Declines Bring Potential Opportunity",
    "summary": "Click here for analysis of HQH closed-end fund: regulatory uncertainty causing pressure, 12% managed distribution policy appeals to yield investors, heavy biotech focus.",
    "url": "https://finnhub.io/api/news?id=44c239cfeeb0fdc5a3deef0037108a1235f7ce99d7fadd3646dc4ce776b971e3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732181066,
      "headline": "HQH: Declines Bring Potential Opportunity",
      "id": 131538682,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1255266014/image_1255266014.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Click here for analysis of HQH closed-end fund: regulatory uncertainty causing pressure, 12% managed distribution policy appeals to yield investors, heavy biotech focus.",
      "url": "https://finnhub.io/api/news?id=44c239cfeeb0fdc5a3deef0037108a1235f7ce99d7fadd3646dc4ce776b971e3"
    }
  },
  {
    "ts": null,
    "headline": "AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market",
    "summary": "Autolus Therapeutics' AUCATZYL shows strong potential despite safety concerns. Find out why AUTL stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=9df3850707cc7bef33c63cacaa51089c0818be8a08bf858f0aaac120f7f5ba62",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732148181,
      "headline": "AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market",
      "id": 131524735,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154252378/image_2154252378.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Autolus Therapeutics' AUCATZYL shows strong potential despite safety concerns. Find out why AUTL stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=9df3850707cc7bef33c63cacaa51089c0818be8a08bf858f0aaac120f7f5ba62"
    }
  }
]